HIGH-PRIORITY ACTIVITIES

  • Market introduce EDOR®– in cooperation with clinical centres that have participated in EUDOR-A, arrange local training courses for new psychiatric centres in Europe
  • Initiate the launch of our method, both domestically and in select countries.
  • Aim our marketing efforts at the 10,000 psychiatric clinics that participate in the large international conventions in the subject area
  • In cooperation with clinical and research oriented ambassadors, standing behind EDOR®, present results from EUDOR-A and previous studies, which demonstrate the strong relation between the test results and vulnerability to suicide actions.
  • Make sure these clinics publish their results in internationally respected scientific publications and present them at international scientific conventions
  • Develop patented technology for server-based analysis of test results
  • Complete development of the next generation of our product system to meet successively increasing demands from the marketMAIN GOALS
  • Achieve a steady sales growth of EDOR® and a successively increased test activity
  • Enlist 15–18 internationally leading clinics to act as key ambassadors for EDOR® until end of 2017
  • Have at least two scientific articles published, showing that the experiences at a number of independent clinics confirm Thorell’s strong clinical results
  • Get several clinics/researchers, including Thorell, invited to present their experiences of EDOR® at the most important international conferences
  • Ensure that the capacity of EDOR® is not a bottleneck for growth after 2017
  • Achieve positive earnings so that the Company is able to self-finance future investments in continued market penetration and product development